Could Navidea Biopharmaceuticals Inc. (NAVB) stock price achieve new all-time highs if its expected earnings and revenue increase?
In yesterday’s Wall Street session, Navidea Biopharmaceuticals Inc. (AMEX:NAVB) shares traded at $0.10, up 7.15% from the previous session. As of this writing, 1 analysts cover Navidea Biopharmaceuticals Inc. (AMEX:NAVB). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $8.00 and a […]
Can Navidea Biopharmaceuticals Inc. (NAVB) stock recover despite sales dropping?
In yesterday’s Wall Street session, Navidea Biopharmaceuticals Inc. (AMEX:NAVB) shares traded at $0.12, up 3.45% from the previous session. 1 analysts cover Navidea Biopharmaceuticals Inc. (AMEX:NAVB), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $8.00 and a […]
A Stock With Stellar Fundamentals? Navidea Biopharmaceuticals Inc. (AMEX:NAVB): Is It Right For You?
In yesterday’s Wall Street session, Navidea Biopharmaceuticals Inc. (AMEX:NAVB) shares traded at $0.09, down -9.38% from the previous session. As of this writing, 1 analysts cover Navidea Biopharmaceuticals Inc. (AMEX:NAVB). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $8.00 and a […]
Can Navidea Biopharmaceuticals Inc. (NAVB) stock recover despite sales dropping?
In yesterday’s Wall Street session, Navidea Biopharmaceuticals Inc. (AMEX:NAVB) shares traded at $0.12, down -1.67% from the previous session. 1 analysts cover Navidea Biopharmaceuticals Inc. (AMEX:NAVB), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $8.00 and a […]
A Stock With Stellar Fundamentals? Navidea Biopharmaceuticals Inc. (AMEX:NAVB): Is It Right For You?
In yesterday’s Wall Street session, Navidea Biopharmaceuticals Inc. (AMEX:NAVB) shares traded at $0.09, up 4.64% from the previous session. As of this writing, 1 analysts cover Navidea Biopharmaceuticals Inc. (AMEX:NAVB). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $8.00 and a […]